Disruptor of telomeric silencing 1-like (DOT1L) is involved in breast cancer metastasis via transcriptional regulation of MALAT1 and ZEB2

J Genet Genomics. 2019 Dec 20;46(12):591-594. doi: 10.1016/j.jgg.2019.11.008. Epub 2019 Dec 17.

¹ Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Key Laboratory of Spine and Spinal Cord, Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin, 300070, China; Department of Gynecology, Tianjin Medical University NanKai Hospital, Tianjin 300100, China.
² Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Key Laboratory of Spine and Spinal Cord, Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin, 300070, China.
³ Department of Genetics and Cell Biology, College of Life Sciences, Nankai University, Tianjin 300071, China.
⁴ Department of Pharmacology, Tianjin Medical University, Tianjin, 300070, China.
⁵ Department of Genetics and Cell Biology, College of Life Sciences, Nankai University, Tianjin 300071, China; Institute of Biomedical Sciences, College of Life Sciences, Shandong Normal University, Shandong 250014, China.
⁶ Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Tianjin Key Laboratory of Spine and Spinal Cord, Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin, 300070, China. Electronic address: [email protected].

No abstract available

Publication types